U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07036796) titled 'Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy' on June 17.
Brief Summary: The aim of the current study is to measure the effect of melatonin as adjunct therapy on oxidative stress, inflammatory markers and clinical outcome in type 2 diabetic patients with diabetic peripheral neuropathy.
Study Start Date: July 04
Study Type: INTERVENTIONAL
Condition:
Diabetic Peripheral Neuropathy
Diabetic Neuropathy
Diabetic Peripheral Neuropathy in Type 2 Diabetic Patients
Intervention:
DRUG: Melatonin
Melatonin (N-acetyl-5-methoxytryptamine), also called the hormone of darkness, secreted primarily by the pineal gland. ...